Patent ID: 6982332
Filing Date: 2006-01-03
Classification: A61K,A61P,C07D

Abstract:
1. A compound exhibiting CNS activity in mammalian species, having the structure wherein A is an optionally heterocyclic 5 or 6 membered aromatic ring system; is an optionally heteroevelic 5 or 6 membered aromatic ring structure wherein X and Y are moieties which complete said 5 or 6 membered aromatic ring system. R o is an integer from 0 to 4, the upper limit of o bounded by the number of available substitutent sites on said optionally heterocyclic 5 or 6 membere aromatic ring structure; n is an integer from 0 to 2; R p is 1 to 4; wherein one (CH or a pharmaceutically acceptable salt thereof.